Long-Term Survival in Patients with or without Implantable Cardioverter Defibrillator after Transcatheter Aortic Valve Implantation.
TAVI
aortic stenosis
implantable cardioverter defibrillator
survival
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
30 Jun 2021
30 Jun 2021
Historique:
received:
10
05
2021
revised:
25
06
2021
accepted:
26
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
Patients with symptomatic aortic stenosis (AS) can have concomitant systolic heart failure (HF) that persists even after correction of afterload by transcatheter aortic valve implantation (TAVI). These patients qualify as potential candidates for prophylactic therapy with an implantable cardioverter defibrillator (ICD). We compared survival between patients with or without an ICD after successful TAVI. This retrospective study analyzed Kaplan-Meier survival data during a follow-up period of three years in two populations: (a) patients with a left ventricular ejection fraction (LVEF) ≤ 35% before TAVI (overall population); (b) patients with additionally documented LVEF ≤ 35% 3 months after TAVI (persistent LV dysfunction subpopulation). In the overall population, 53 patients with and 193 patients without an ICD had similar baseline characteristics and procedural success rates, and HF medication at discharge was comparable. Three-year mortality rates were 26.4% for patients with an ICD and 24.4% for patients without an ICD (
Identifiants
pubmed: 34208816
pii: jcm10132929
doi: 10.3390/jcm10132929
pmc: PMC8268788
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
ESC Heart Fail. 2018 Oct;5(5):884-891
pubmed: 29936703
Am Heart J. 2006 Oct;152(4):714-9
pubmed: 16996846
PLoS One. 2019 Nov 26;14(11):e0225473
pubmed: 31770401
Eur J Cardiothorac Surg. 2012 Nov;42(5):S45-60
pubmed: 23026738
Eur Heart J. 2017 Sep 21;38(36):2739-2791
pubmed: 28886619
Eur J Heart Fail. 2016 May;18(5):469-81
pubmed: 26725980
Eur J Heart Fail. 2011 May;13(5):528-36
pubmed: 21454299
Clin Res Cardiol. 2019 Jul;108(7):741-748
pubmed: 30506481
Eur Heart J. 2015 Nov 1;36(41):2793-2867
pubmed: 26320108
N Engl J Med. 2005 Jan 20;352(3):225-37
pubmed: 15659722
J Am Coll Cardiol. 2007 Jun 26;49(25):2408-15
pubmed: 17599603
N Engl J Med. 2002 Mar 21;346(12):877-83
pubmed: 11907286
Am J Cardiol. 2014 Mar 1;113(5):851-9
pubmed: 24528616
Am J Cardiol. 2012 Dec 1;110(11):1663-6
pubmed: 22920927
J Thorac Cardiovasc Surg. 2014 Jan;147(1):362-369.e8
pubmed: 23312984
Eur J Heart Fail. 2020 Oct;22(10):1866-1874
pubmed: 32441856
Ann Intern Med. 2010 Nov 2;153(9):592-9
pubmed: 21041579
Europace. 2015 Jul;17(7):1136-40
pubmed: 25995390
JACC Cardiovasc Interv. 2017 Dec 11;10(23):2426-2436
pubmed: 29217006
Ann Thorac Surg. 2020 Jan;109(1):110-117
pubmed: 31288017
Ann Thorac Surg. 2015 May;99(5):1503-09; discussion 1509-10
pubmed: 25840608
Circ Cardiovasc Qual Outcomes. 2009 Jan;2(1):16-24
pubmed: 20031808
Circulation. 2006 Mar 21;113(11):1424-33
pubmed: 16534009
N Engl J Med. 2016 Sep 29;375(13):1221-30
pubmed: 27571011